Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Apellis Pharmaceuticals buy Vassago1

Apellis Pharmaceuticals
Start price
€44.20
10.11.22 / 50%
Target price
-
10.11.23
Performance (%)
49.32%
End price
€66.00
02.04.23
Summary
This prediction ended on 02.04.23 with a price of €66.00. The BUY prediction by Vassago1 for Apellis Pharmaceuticals saw massive gains of 49.32%. Vassago1 has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Apellis Pharmaceuticals - - - -
iShares Core DAX® 0.734% 1.458% 17.980% 65.292%
iShares Nasdaq 100 -2.686% -0.146% 3.810% 97.467%
iShares Nikkei 225® -2.261% -2.729% 11.679% 39.755%
iShares S&P 500 -1.346% 0.467% 1.970% 61.093%

According to Vassago1 what are the pros and cons of Apellis Pharmaceuticals for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by Vassago1 for this prediction

In the thread Apellis Pharmaceuticals diskutieren

Buy Apellis Pharmaceuticals

Vassago1 
0
Report Share
10.11.22 Buy 49.32%
In the thread Trading Apellis Pharmaceuticals
Prediction Buy
Perf. (%) 49.32%
Target price
Change
Ends at 10.11.23

Buy beendet

Vassago1 
0
Report Share
02.04.23

Stopped prediction by Vassago1 for Apellis Pharmaceuticals

buy
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€17.39
07.04.25
-
07.04.26
-2.13%
14.04.25

Could be worthwhile Investment >10% per year
Vassago1 
07.04.25 50%
buy
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€23.80
31.07.23
-
31.07.24
-5.04%
05.08.23

Vassago1 
31.07.23 50%
buy
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€46.60
17.07.23
-
17.07.24
-33.05%
22.07.23

Vassago1 
17.07.23 50%